Quick Facts at a Glance
- Recall Date
- March 20, 2026
- Hazard Level
- HIGH
- Brand
- Fagron Compounding Services
- Category
- Health & Personal Care
- Sold At
- Unknown
- Geographic Scope
- 1 states
- At-Risk Groups
- GENERAL, PREGNANT, PETS
What to Do Now
Use this page like a recall checklist: verify the product first, then act on the official remedy.
Immediate steps
- 1Stop using the product until you confirm whether it is included in the recall.
- 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
- 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
- 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.
Check these identifiers
- Brand
- Fagron Compounding Services
- Product type
- Vancomycin HCI Injection
- Model numbers
- Lot: C274-000050857, Exp.:7/6/2026, C274-000049316, Exp.: 4/26/2026, C274-000049367, Exp.: 4/28/2026, C274-000049496, Exp.: 5/3/2026 +12 more
- Sold at
- Unknown
- Where affected
- ALL
Recall Timeline
Key dates and source checks for this recall record.
Recall announced
March 20, 2026
Reported by FDA DRUG
April 15, 2026
RecallRadar source check
April 22, 2026
Consumer action
Use the official remedy and keep documentation.
Hazard Information
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
What You Should Do
Consumers and healthcare providers should stop using this product immediately. Contact Fagron Compounding Services or your healthcare provider for guidance. Notification method: Letter
About This Product
Vancomycin HCI is an antibiotic administered intravenously. This recall involves a compounded sterile product prepared by Fagron Compounding Services for distribution nationwide.
Why This Is Dangerous
A blue Break-Off-Part could detach from the administration port, potentially compromising sterile integrity and allowing contamination.
Industry Context
This recall is not described as part of a broader industry pattern in the provided data.
Real-World Impact
High risk for sterile administration products used in clinical settings; delays or substitutions may affect patient care.
Practical Guidance
How to identify if yours is affected
- Locate the lot number on the product carton and vial sticker
- Cross-check with the FDA recall listing D-0440-2026
- Verify expiration date 4/26/2026 through 7/6/2026
Where to find product info
FDA enforcement report D-0440-2026 and recall notification letters
What timeline to expect
Refunds/replacements coordinated by Fagron with healthcare facilities; timelines may vary by institution
If the manufacturer is unresponsive
- Escalate to hospital risk management
- Contact FDA recalls program for guidance
- Seek alternative suppliers with proper sterility assurance
How to prevent similar issues
- Vet compounding suppliers for sterility programs
- Confirm sterile processing certifications
- Request lot-level traceability and ensure proper handling
Documentation advice
Keep all recall notices, lot numbers, expiration dates, and correspondence with supplier
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Product Details
Brand: Fagron Compounding Services. Product: Vancomycin HCI, 1.25 g added to 250 mL, 0.9% Sodium Chloride Injection USP. NDC: 71266-5083-01. Quantity: 34,260 bags. Distribution: Nationwide in the USA. Lot numbers and expirations listed in the notice.
Reported Incidents
No specific injuries or incidents are documented in the provided recall notice.
Key Facts
- Class II recall
- Nationwide distribution in USA
Browse More Recalls
Safety Guide
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet Alerts for Health & Personal Care Recalls
Get instant alerts for recalls that affect you. Free forever.